EU RoHS Directive Annex III and IV Exemptions

Article 4 says the RoHS substance restriction does not apply to applications listed in Annexes III and IV. Article 5 then explains how materials and components of EEE for specific applications can be included in those annexes by delegated acts.

Annex III is the general exemption list used across RoHS EEE categories. Annex IV is for applications specific to medical devices and monitoring and control instruments. Do not treat a substance name alone as enough: the exemption wording, EEE category, dates, and application boundaries decide whether it fits.

Article 5 allows an exemption only where the inclusion does not weaken REACH environmental and health protection and at least one listed condition is met. The directive points to scientific or technical impracticability of elimination or substitution, reliability of substitutes, or cases where the negative environmental, health, and consumer-safety impacts of substitution are likely to outweigh the benefits.

The Commission must also consider substitute availability, socioeconomic impact, potential adverse impacts on innovation, and life-cycle thinking where relevant. The guidance document warns that meeting a criterion does not automatically secure an exemption; the criteria frame the justification and the Commission still decides the outcome.

For exemptions granted under Article 5(1)(a), the directive sets validity periods of up to 5 years for Annex I categories 1 to 7, 10, and 11, and up to 7 years for categories 8 and 9. Annex III entries that existed on 21 July 2011 have category-specific maximum periods unless a shorter period is specified; Annex IV entries that existed on that date have a maximum 7-year period from the relevant Article 4(3) dates unless shorter timing is specified.

Renewal timing is operationally important. A renewal application must be made no later than 18 months before the exemption expires. If a renewal request has been submitted, the existing exemption remains valid until the Commission takes a decision. If renewal is rejected or an exemption is revoked, the directive provides a 12 to 18 month expiry window after the decision.

A usable exemption record should prove more than the fact that an annex entry exists. It should connect the entry to the product, EEE category, homogeneous material, substance, component function, supplier evidence, expiry status, and technical-documentation file.

Annex V identifies the minimum information for exemption applications, including applicant details, material or component information, specific substance uses, verifiable and referenced justification, alternatives analysis on a life-cycle basis, reuse or recycling information, actions and timetables for alternatives, confidentiality claims where appropriate, and proposed precise wording. Even when a company is only relying on an existing exemption, those fields are a useful evidence model.

Most mistakes come from treating an exemption as a general material allowance. RoHS exemptions attach to specific applications and often to specific EEE categories or subcategories. A lead, cadmium, or mercury use that fits one entry may still fail if the product category, component function, or expiry condition is different.

Another risk is stale monitoring. The Commission page explains that exemptions are reassessed regularly, and the consolidated directive shows many annex entries with detailed category-specific expiry language. A product-release checklist should therefore include exemption status review, not just a one-time annex lookup.